Skip to content
Bristol Myers Squibb (BMS)
-
Bristol Myers Squibb’s RayzeBio to build US$173M radiopharmaceutical facility in Indiana
The new site will complement RayzeBio’s existing 77,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, located about 20 miles southwest of Whitestown.
-
Bristol Myers Squibb expands US manufacturing footprint with US$2.3B Houston facility
The investment forms part of BMS’ broader US$ 40 billion commitment to strengthening its US operations, including its manufacturing and research and development (R&D) capabilities.